Hepatoma Research (HR) is an international peer-reviewed, open access, online journal.
The journal focuses on all topics related to hepatoma, including its occurrence, development, diagnosis, and treatment. The coverage also extends to other basic and clinical studies related to surgery, internal medicine, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, etc.
The journal publishes the following types of articles: Review Article, Original Article, Case Report, Commentary, Editorial, Research Highlight, etc. Manuscripts with videos are welcome.
The journal is owned by OAE Publishing Inc.
All articles published by HR are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access. Articles had been published under Attribution-NonCommercial-ShareAlike 3.0 Unported till October 2017, whereas the Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Authors retain the copyright of their works as well as the rights to make certain uses of the works.
For more information about the editorial team, please refer to Editorial Board.
All manuscripts submitted to HR should adhere to OAE's Editorial Policies.
The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Hepatoma Research take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.
Please visit the Contact Us for details about different queries.